S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
NASDAQ:DH

Definitive Healthcare (DH) Stock Forecast, Price & News

$7.89
+0.08 (+1.02%)
(As of 09/22/2023 ET)
Compare
Today's Range
$7.74
$8.04
50-Day Range
$7.77
$12.12
52-Week Range
$7.58
$17.39
Volume
564,356 shs
Average Volume
751,126 shs
Market Capitalization
$893.94 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.69

Definitive Healthcare MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
60.8% Upside
$12.69 Price Target
Short Interest
Healthy
16.75% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Selling Shares
$62,500 Sold Last Quarter
Proj. Earnings Growth
166.67%
From $0.03 to $0.08 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.55 out of 5 stars

Medical Sector

142nd out of 968 stocks

Prepackaged Software Industry

47th out of 199 stocks


DH stock logo

About Definitive Healthcare (NASDAQ:DH) Stock

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing firms and commercial real estate companies, financial institutions, and other organizations in the healthcare ecosystem. The company was founded in 2011 and is headquartered in Framingham, Massachusetts.

DH Price History

DH Stock News Headlines

Laser breakthrough could send stock soaring 2,467%
Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...
Definitive Healthcare (NASDAQ: DH)
Laser breakthrough could send stock soaring 2,467%
Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...
Definitive Healthcare acquires Populi
Earnings Preview For Definitive Healthcare
The Latest Analyst Ratings for Definitive Healthcare
Definitive Healthcare expands the Atlas Dataset
See More Headlines
Receive DH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Definitive Healthcare and its competitors with MarketBeat's FREE daily newsletter.

DH Company Calendar

Last Earnings
8/14/2023
Today
9/22/2023
Next Earnings (Estimated)
11/02/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
946
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$12.69
High Stock Price Forecast
$15.50
Low Stock Price Forecast
$10.00
Forecasted Upside/Downside
+60.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
8 Analysts

Profitability

Net Income
$-7,220,000.00
Pretax Margin
-20.08%

Debt

Sales & Book Value

Annual Sales
$222.65 million
Cash Flow
$0.71 per share
Book Value
$14.10 per share

Miscellaneous

Free Float
95,998,000
Market Cap
$893.94 million
Optionable
Not Optionable
Beta
0.74
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Jason Ronald Krantz (Age 49)
    Founder & Exec. Chairman
    Comp: $820.92k
  • Mr. Robert W. Musslewhite J.D. (Age 53)
    CEO & Director
    Comp: $709.08k
  • Mr. Jon Maack
    Pres
  • Mr. Richard Douglas BoothMr. Richard Douglas Booth (Age 54)
    Chief Financial Officer
    Comp: $562.44k
  • Mr. Joseph Gianni Mirisola (Age 39)
    Chief Revenue Officer
    Comp: $402.2k
  • Ms. Kate Marie Shamsuddin Jensen (Age 37)
    Chief Product Officer
    Comp: $393.26k
  • Mr. Scott Oberlink
    Chief Technology Officer
  • Mr. Matt Ruderman
    Chief Legal Officer & Sec.
  • Mr. Justin A. Steinman
    Chief Marketing Officer
  • Mr. Ram Sharma
    Exec. VP of Life Sciences













DH Stock - Frequently Asked Questions

Should I buy or sell Definitive Healthcare stock right now?

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Definitive Healthcare in the last year. There are currently 4 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" DH shares.
View DH analyst ratings
or view top-rated stocks.

What is Definitive Healthcare's stock price forecast for 2023?

8 brokerages have issued 1-year price targets for Definitive Healthcare's shares. Their DH share price forecasts range from $10.00 to $15.50. On average, they anticipate the company's stock price to reach $12.69 in the next twelve months. This suggests a possible upside of 60.8% from the stock's current price.
View analysts price targets for DH
or view top-rated stocks among Wall Street analysts.

How have DH shares performed in 2023?

Definitive Healthcare's stock was trading at $10.99 on January 1st, 2023. Since then, DH shares have decreased by 28.2% and is now trading at $7.89.
View the best growth stocks for 2023 here
.

Are investors shorting Definitive Healthcare?

Definitive Healthcare saw a decline in short interest in the month of August. As of August 31st, there was short interest totaling 6,400,000 shares, a decline of 31.9% from the August 15th total of 9,400,000 shares. Based on an average daily volume of 648,600 shares, the days-to-cover ratio is presently 9.9 days. Currently, 16.8% of the shares of the stock are sold short.
View Definitive Healthcare's Short Interest
.

When is Definitive Healthcare's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023.
View our DH earnings forecast
.

How were Definitive Healthcare's earnings last quarter?

Definitive Healthcare Corp. (NASDAQ:DH) announced its quarterly earnings results on Monday, August, 14th. The company reported $0.08 EPS for the quarter, topping the consensus estimate of $0.05 by $0.03. The business earned $60.96 million during the quarter, compared to the consensus estimate of $61 million. Definitive Healthcare had a positive trailing twelve-month return on equity of 0.29% and a negative net margin of 5.31%. The business's quarterly revenue was up 11.7% on a year-over-year basis. During the same period in the previous year, the business earned ($0.01) earnings per share.

What ETFs hold Definitive Healthcare's stock?
What guidance has Definitive Healthcare issued on next quarter's earnings?

Definitive Healthcare updated its third quarter 2023 earnings guidance on Monday, August, 14th. The company provided earnings per share guidance of $0.05-$0.07 for the period, compared to the consensus estimate of $0.05. The company issued revenue guidance of $63.00 million-$64.50 million, compared to the consensus revenue estimate of $64.24 million.

When did Definitive Healthcare IPO?

(DH) raised $350 million in an initial public offering (IPO) on Wednesday, September 15th 2021. The company issued 15,555,555 shares at $21.00-$24.00 per share.

What is Definitive Healthcare's stock symbol?

Definitive Healthcare trades on the NASDAQ under the ticker symbol "DH."

Who are Definitive Healthcare's major shareholders?

Definitive Healthcare's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Conestoga Capital Advisors LLC (4.94%), JPMorgan Chase & Co. (4.62%), Brown Advisory Inc. (3.58%), BlackRock Inc. (3.38%), Riverbridge Partners LLC (2.63%) and Clearbridge Investments LLC (2.06%). Insiders that own company stock include David Randall Winn, Jeffrey Charles Haywood, Richard Douglas Booth and Sea Vii Management, Llc.
View institutional ownership trends
.

How do I buy shares of Definitive Healthcare?

Shares of DH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Definitive Healthcare's stock price today?

One share of DH stock can currently be purchased for approximately $7.89.

How much money does Definitive Healthcare make?

Definitive Healthcare (NASDAQ:DH) has a market capitalization of $893.94 million and generates $222.65 million in revenue each year. The company earns $-7,220,000.00 in net income (profit) each year or ($0.15) on an earnings per share basis.

How many employees does Definitive Healthcare have?

The company employs 946 workers across the globe.

How can I contact Definitive Healthcare?

Definitive Healthcare's mailing address is 550 COCHITUATE ROAD, FRAMINGHAM MA, 01701. The official website for the company is www.definitivehc.com. The company can be reached via phone at 508-720-4224 or via email at ir@definitivehc.com.

This page (NASDAQ:DH) was last updated on 9/22/2023 by MarketBeat.com Staff

My Account -